Navigation Links
Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries

Diflucan Partnership seems to be the latest mantra of Pfizer. The pharmaceutical giant has announced that it will supply free antifungal drug to 50 countries hardest hit by the AIDS virus. The decision by the Pfizer comes close on the heels of the South African Government winning a landmark case against pharmaceutical companies. In an announcement on Wednesday Pfizer said AIDS related antifungal drug Diflucan will be given free of cost to battle HIV through a programe to be coordinated by World Health Organization and the United Nations.

"Together with our partners in the United Nations and the WHO, we now have a framework to offer Diflucan to the least-developed nations targeted by the UN and the WHO as the most affected by the AIDS crisis", Dr.Henry McKinnell, CEO of Pfizer, told reporters at a press conference.

Many patients stricken with AIDS develop complication of fungal origin. Two common conditions are esophageal candidiasis and cryptococcal meningitis. Flucanazole, commerically available as Diflucan is used to treat these conditions.

Representatives of Pfizer Inc. said they do not know how much the expanded 50-nation program would cost. However, they said that expenses of the project, called the Diflucan Partnership, would include drug manufacturing, shipping, transportation, medical training and patient education.
'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Medicis Pharmaceutical company enters pediatric market
3. Pharmaceutical companies are targeting patients
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
7. Pharmaceutical industries grant for R&D to be monitored
8. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
9. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
10. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
11. Top Pharmaceuticals Influence Doctors Prescriptions
Post Your Comments:
(Date:5/16/2008)...National HIV Vaccine Awareness Day, May,18, WASHI...x years into the,AIDS epidemic, someone is newly i...unday, May 18, HIV Vaccine Awareness Day, AIDS Act... Institute of Allergy and Infectious,Disease (NIAI...s everyone,to help end the AIDS epidemic by partic...
(Date:5/16/2008)...untsworth plc (LSE: HNT), "the Group",a leading i...nications,group headquartered in London, released ...Group,s performance in the first quarter 2008 (the...follows below., 15 May 2008, ...erim Management Statement, Record net ...
(Date:5/16/2008)... More in 2007, WASHINGTON, May 16 /PRNewswire-USN...cancer deaths, the National Cancer Institute (NCI)...in lung cancer research in 2007,according to upda...) today., The two other federal agencies with sig...isease Control and Prevention (CDC) and the,Depart...
(Date:5/16/2008)...Comprehensive Income increased 42% to $9.7 million... - 2007 Gross Margin of 76%, - Product Sales Back... million from $2.4 million as of December 31, 200...stCall/ -- Huiheng,Medical, Inc. ("Huiheng" or the...sed leader in the development, sales and support o...
Breaking Medicine News(10 mins):Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:Lung Cancer Still Lowest in Federal Funding 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 2Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 3Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 4Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 5Health News:Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008 6
...n for cancer, anyone? Yes, Oxford University resea...can prevent bowel cancer developing . Taking a dos...tion. Long-term aspirin use is generally not back...mach problems, but the team said it could benefit ...
...a research reveals that two thirds of those who ta...delines before doing so. In other words , those us...so on the basis of blind faith and do not care to ...ms or seek evidence based results. The researcher...
...S federal receiver Robert Sillen, hired to improve...bitious turnaround plan for his jurisdiction. Ac... the unconscionable human suffering" in prison and...es from diseases carried by inmates cycling in and...
...g man working as a cleaner for a Tasmanian school ...pturing children in the bathroom on film , and mak... of Hobart pleaded guilty to three counts of indec...child exploitation material, and one count of poss...
Other Medicine News:Health News:Aspirin can Prevent Bowel Cancer, Says UK Study 2Health News:Blind Faith Dictates Use Of Herbal Supplements In Many 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 2Health News:Brickbats And Bouquets For U.S Prison Healthcare In-Charge 3
(Date:5/15/2008)...ch, a publishing and,information services company ...finds that investigative sites are required to lea... More than 75% of respondents to a recent,CenterWa... three or more,EDC systems. In addition, a majorit...aining had improved., State of the Clinical Trial...
(Date:5/15/2008)...Call/ -- Novavax, Inc. (Nasdaq:,NVAX) today announ...I/IIa,study of its pandemic influenza vaccine incl...able interim results from the first phase of the s... adult volunteers, were,reported in December 2007....s well tolerated and immunogenic at the 15 microgr...
(Date:5/15/2008)...tions Blue Cross Blue Shield of Michigan to W... HealthLeaders-InterStudy, NA...rs-InterStudy, the,leading provider of managed car... continues to stagnate in Michigan, Blue Cross Blu...all of its competitors to weather the,economic sto...
(Date:5/15/2008)... Genous, Boston Scientific,s ...eal-World Use of Genous, Stent,s Performance in P...l-Antiplatelet Ther...usNeich today announced,that multiple clinical dat...port the use of the company,s Genous Bio-engineere...
Breaking Medicine Technology:CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 2Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial 3Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 2Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 3Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents 4Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 1Lauren Marangell M D to Join Lilly 3B Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar 1723 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 1CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 2CRC Health Group Announces Acquisition of Durhams Structure House Weight Loss Facility 1721 3GrantAdler Shipping Novel Implantable Vascular Access Port 1719 1GrantAdler Shipping Novel Implantable Vascular Access Port 1719 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 1Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 2Eight Michigan HMOs Two Providers Take Top Honors for Quality Health Care 1717 3
...re-FirstCall/ --,Schering-Plough Corporation annou...ts novel oral thrombin receptor antagonist (TRA),S...entific Sessions,of the of Cardiology (ACC.07)/Inn...n New Orleans. The Phase II trial, referred to,as ...oronary,Intervention (TRA-PCI) trial, has been acc...
...an TNFa, LAUSANNE, Switzerland, March 12, 2007 /PR...al independent biopharmaceutical,development compa...nditions, announces the presentation of preclinica... Debio-0512 as an anti-TNFa,therapeutic vaccine, t...ls of acute and chronic inflammation. Debio-0512 i...
Other Medicine Technology:Schering-Plough Announces Presentation of Phase II Trial Results,for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual,Meeting of The American College of Cardiology/i2 Summit 2Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2
...ystem treats female urinary stress incontinence (S...er a suprapubic (BioArcTM SP) or a transobturator ...e hybrid system combining synthetic and biologic m...ailable. The BioArc utilizes a polypropylene mesh ...
...ing System utilizes a suprapubic approach to treat...l hypermobility and/or intrinsic sphincter deficie... needles and a self-fixating sling with a resorbab...ve tension refinement without mesh distortion, as ...
...Ultra Sling is a minimally invasive treatment for ...repair surgery can be performed at the same time. ...e a sling, the In-Fast Ultra inserter is used to d...rior aspect of the pubic bone. Each screw has a su...
Proven tension-free sling technology marries with the well-researched Pelvicol® porcine acellular collagen matrix sling, for exceptional resultsby design. Natural tissue-to-tissue contact between
Medicine Products: